circRNF220

ncRNA information

ncRNA

circRNF220

Specific or universal ncRNAs

Specific ncRNAs

Class

Circular RNA

Biomarker

None

Biomarker application

Upstream regulatory factor

Not available

Downstream target

miR-30a/MYSM1/IER2

Differential expression in
recurrence vs. nonrecurrence

Not available

Cancer information

Cancer name

Pediatric Acute Myeloid Leukemia

Alias

Leukemia

Cancer site

Leukemia

Recurrence type

Recurrence

Clinical information

Overall survival rate of patients with
high ncRNA expression

Not available

ncRNA differential expression in
cancer patients vs. health people

Up

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available


Recurrence patients

Not available

Recurrence patients male:female

Not available

Recurrence patients age range

Not available

Recurrence mean age

Not available

Sites of recurrence

Not available


Patients without recurrence

Not available

Patients without recurrence male:female

Patients without recurrence age range

Not available

Patients without recurrence mean age

Not available

Research information

PMID

Description

these findings demonstrated that circRNF220 could be highly efficient and specific for the accurate diagnosis of pediatric AML, with implications for relapse prediction

Tissue resource

human leukemia cell lines K562

human embryonic kidney cell lines HEK-293T

bone marrow and peripheral blood samples from pediatric patients

human leukemia cell lines HL-60

human leukemia cell lines THP-1

Experiment

qRT-PCR


Institute

American Type Culture Collection

American Type Culture Collection

Guangzhou Women and Children's Medical Center of Guangzhou Medical University

American Type Culture Collection

American Type Culture Collection

Country

USA

USA

China

USA

USA

Continent

North American

North American

Asia

North American

North American